LEP and breast carcinoma: In our meta-analysis, we combined all publications addressing the association of the Leptin -2548G/A gene polymorphism and breast cancer risk before August 10, 2015, and the results revealed a significantly elevated breast cancer risk, we pooled all 9 eligible case–control studies to estimate the breast cancer risk of the Leptin-2548G/A genes.